Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
68.88
+3.25 (4.95%)
At close: Feb 3, 2026, 4:00 PM EST
68.89
+0.01 (0.01%)
After-hours: Feb 3, 2026, 4:10 PM EST
Apogee Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$103.33
Upside
+50.01%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy → Hold Downgrades $70 → $83 | Buy → Hold | Downgrades | $70 → $83 | +20.50% | Jan 22, 2026 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Jan 7, 2026 |
| BTIG | BTIG | Strong Buy Maintains $128 → $137 | Strong Buy | Maintains | $128 → $137 | +98.90% | Jan 6, 2026 |
| BTIG | BTIG | Strong Buy Maintains $115 → $128 | Strong Buy | Maintains | $115 → $128 | +85.83% | Jan 5, 2026 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $95 | Buy | Initiates | $95 | +37.92% | Dec 17, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy Initiates $103 | Strong Buy | Initiates | $103 | +49.54% | Dec 10, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $109 | Strong Buy | Initiates | $109 | +58.25% | Nov 3, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $60 → $70 | Buy | Maintains | $60 → $70 | +1.63% | Nov 3, 2025 |
| Mizuho | Mizuho | Buy Initiates $105 | Buy | Initiates | $105 | +52.44% | Oct 21, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $115 | Strong Buy | Reiterates | $115 | +66.96% | Oct 9, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $60 | Buy | Initiates | $60 | -12.89% | Sep 25, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $78 → $87 | Strong Buy | Maintains | $78 → $87 | +26.31% | Aug 28, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $116 | Strong Buy | Reiterates | $116 | +68.41% | Jul 2, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $95 | Strong Buy | Initiates | $95 | +37.92% | Mar 13, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Feb 10, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Dec 12, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.